Lymphocytic choriomeningitis virus-induced central nervous system disease: A model for studying the role of chemokines in regulating the acute antiviral CD8+ T-cell response in an immune-privileged organ

Journal of Virology

Volumn 83, Issue 1, 2009, Pages 20-28

  Thomsen, Allan Randrup ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR CCR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR; CHEMOKINE RECEPTOR CXCR3; CX3C CHEMOKINE; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ADAPTIVE IMMUNITY; BIOLOGICAL ACTIVITY; CD8+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; ENZYME REGULATION; EXPERIMENTAL MODEL; EXTRAVASATION; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LEUKOCYTE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY; VIRUS INFECTION; VIRUS MENINGITIS; ANIMAL; IMMUNOLOGY; REVIEW;

LYMPHOCYTIC CHORIOMENINGITIS VIRUS;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINES; HUMANS; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS;

EID: 58149401236     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00682-08     Document Type: Short Survey

References (80)

1. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499-511.
2. Allan, J. E., J. E. Dixon, and P. C. Doherty. 1987. Nature of the inflammatory process in the central nervous system of mice infected with lymphocytic choriomeningitis virus. Curr. Top. Microbiol. Immunol. 134:131-143.
3. Alon, R., P. D. Kassner, M. W. Carr, E. B. Finger, M. E. Hemler, and T. A. Springer. 1995. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J. Cell Biol. 128:1243-1253.
4. + T cells. J. Neuroimmunol. 31:155-163.
5. + T cells. Scand. J. Immunol. 42:110-118.
6. Asensio, V. C., and I. L. Campbell. 1997. Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. J. Virol. 71:7832-7840.
7. + T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. USA 96:6873-6878.
8. Barton, G. M., and R. Medzhitov. 2003. Linking Toll-like receptors to IFN-alpha/beta expression. Nat. Immunol. 4:432-433.
9. Berlin, C., R. F. Bargatze, J. J. Campbell, U. H. von Andrian, M. C. Szabo, S. R. Hasslen, R. D. Nelson, E. L. Berg, S. L. Erlandsen, and E. C. Butcher. 1995. α4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80:413-422.
10. Butcher, E. C. 1991. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67:1033-1036.
11. + T cell-dendritic cell interaction. Nature 440:890-895.
12. Ceredig, R., J. E. Allan, Z. Tabi, F. Lynch, and P. C. Doherty. 1987. Phenotypic analysis of the inflammatory exudate in murine lymphocytic choriomeningitis. J. Exp. Med. 165:1539-1551.
13. Cerwenka, A., T. M. Morgan, A. G. Harmsen, and R. W. Dutton. 1999. Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection. J. Exp. Med. 189:423-434.
14. + T cells and memory cells. Int. Immunol. 13:593-600.
15. + effector T cells involved in immune surveillance of the lymphocytic choriomeningitis virus-infected central nervous system. J. Immunol. 176:4235-4243.
16. Christensen, J. E., A. Nansen, T. Moos, B. Lu, C. Gerard, J. P. Christensen, and A. R. Thomsen. 2004. Efficient T-cell surveillance of the CNS requires expression of the CXC chemokine receptor 3. J. Neurosci. 24:4849-4858.
17. + T cells to sites of infection. J. Immunol. 154:5293-5301.
18. 2-integrin (CD18)- and ICAM-1 (CD54)-deficient mice. J. Virol. 70:8997-9002.
19. Christoffersen, P. J., M. Volkert, and J. Rygaard. 1976. Immunological unresponsiveness of nude mice to LCM virus infection. Acta Pathol. Microbiol. Scand. Sect. C 84C:520-523.
20. Cole, G. A., N. Nathanson, and R. A. Prendergast. 1972. Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature 238:335-337.
21. Cole, K. E., C. A. Strick, T. J. Paradis, K. T. Ogborne, M. Loetscher, R. P. Gladue, W. Lin, J. G. Boyd, B. Moser, D. E. Wood, B. G. Sahagan, and K. Neote. 1998. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J. Exp. Med. 187:2009-2021.
22. + T cell-mediated inflammation in the central nervous system of virus-infected mice. J. Immunol. 175:1767-1775.
23. Delhaye, S., S. Paul, G. Blakqori, M. Minet, F. Weber, P. Staeheli, and T. Michiels. 2006. Neurons produce type I interferon during viral encephalitis. Proc. Natl. Acad. Sci. USA 103:7835-7840.
24. + immune T cells. Cell. Immunol. 107:8-14.
25. Doherty, P. C. 1973. Quantitative studies of the inflammatory process in fatal viral meningoencephalitis. Am. J. Pathol. 73:607-622.
26. Doherty, P. C., and R. M. Zinkernagel. 1974. T-cell-mediated immunopathology in viral infections. Transplant. Rev. 19:89-120.
27. Dorner, B. G., A. Scheffold, M. S. Rolph, M. B. Huser, S. H. Kaufmann, A. Radbruch, I. E. Flesch, and R. A. Kroczek. 2002. MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines. Proc. Natl. Acad. Sci. USA 99:6181-6186.
28. Dufour, J. H., M. Dziejman, M. T. Liu, J. H. Leung, T. E. Lane, and A. D. Luster. 2002. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 168:3195-3204.
29. Giunti, D., G. Borsellino, R. Benelli, M. Marchese, E. Capello, M. T. Valle, E. Pedemonte, D. Noonan, A. Albini, G. Bernardi, G. L. Mancardi, L. Battistini, and A. Uccelli. 2003. Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. J. Leukoc. Biol. 73:584-590.
30. Glass, W. G., M. J. Hickey, J. L. Hardison, M. T. Liu, J. E. Manning, and T. E. Lane. 2004. Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis. J. Immunol. 172:4018-4025.
31. Hancock, W. W., B. Lu, W. Gao, V. Csizmadia, K. Faia, J. A. King, S. T. Smiley, M. Ling, N. P. Gerard, and C. Gerard. 2000. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J. Exp. Med. 192:1515-1520.
32. Holst, P. J., and M. M. Rosenkilde. 2003. Microbiological exploitation of the chemokine system. Microbes Infect. 5:179-187.
33. Hornung, V., J. Ellegast, S. Kim, K. Brzozka, A. Jung, H. Kato, H. Poeck, S. Akira, K. K. Conzelmann, M. Schlee, S. Endres, and G. Hartmann. 2006. 5′-Triphosphate RNA is the ligand for RIG-I. Science 314:994-997.
34. Hotchin, J., and H. Weigand. 1961. The effects of pretreatment with x-rays on the pathogenesis of lymphocytic choriomeningitis in mice. I. Host survival, virus multiplication and leukocytosis. J. Immunol. 87:675-681.
35. Hsieh, M. F., S. L. Lai, J. P. Chen, J. M. Sung, Y. L. Lin, B. A. Wu-Hsieh, C. Gerard, A. Luster, and F. Liao. 2006. Both CXCR3 and CXCL10/IFN-inducible protein 10 are required for resistance to primary infection by dengue virus. J. Immunol. 177:1855-1863.
36. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31-37.
37. Kawai, T., K. Takahashi, S. Sato, C. Coban, H. Kumar, H. Kato, K. J. Ishii, O. Takeuchi, and S. Akira. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981-988.
38. + T-cell recruitment and control of West Nile virus encephalitis. J. Virol. 79:11457-11466.
39. Kolb, S. A., B. Sporer, F. Lahrtz, U. Koedel, H. W. Pfister, and A. Fontana. 1999. Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10. J. Neuroimmunol. 93:172-181.
40. + T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virus. J. Virol. 81:4928-4940.
41. + T cells varies with activation state and localization, but not with TCR avidity. J. Gen. Virol. 85:1703-1712.
42. Kumar, H., T. Kawai, H. Kato, S. Sato, K. Takahashi, C. Coban, M. Yamamoto, S. Uematsu, K. J. Ishii, O. Takeuchi, and S. Akira. 2006. Essential role of IPS-1 in innate immune responses against RNA viruses. J. Exp. Med. 203:1795-1803.
43. Kunkel, E. J., J. Boisvert, K. Murphy, M. A. Vierra, M. C. Genovese, A. J. Wardlaw, H. B. Greenberg, M. R. Hodge, L. Wu, E. C. Butcher, and J. J. Campbell. 2002. Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am. J. Pathol. 160:347-355.
44. Lahrtz, F., L. Piali, D. Nadal, H. W. Pfister, K. S. Spanaus, M. Baggiolini, and A. Fontana. 1997. Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon-gamma inducible protein-10 and monocyte chemotactic protein-1. Eur. J. Immunol. 27:2484-2489.
45. Lang, K. S., A. A. Navarini, M. Recher, P. A. Lang, M. Heikenwalder, B. Stecher, A. Bergthaler, B. Odermatt, S. Akira, K. Honda, H. Hengartner, and R. M. Zinkernagel. 2007. MyD88 protects from lethal encephalitis during infection with vesicular stomatitis virus. Eur. J. Immunol.
46. Leist, T. P., S. P. Cobbold, H. Waldmann, M. Aguet, and R. M. Zinkernagel. 1987. Functional analysis of T lymphocyte subsets in antiviral host defense. J. Immunol. 138:2278-2281.
47. + T cells following an acute virus infection. Eur. J. Immunol. 33:2736-2743.
48. Lindow, M., A. Nansen, C. Bartholdy, A. Stryhn, N. J. V. Hansen, T. P. Boesen, T. N. C. Wells, T. W. Schwartz, and A. R. Thomsen. 2003. The virus-encoded chemokine vMIP-II inhibits virus-induced Tc1-driven inflammation. J. Virol. 77:7393.
49. Loetscher, P., A. Pellegrino, J. H. Gong, I. Mattioli, M. Loetscher, G. Bardi, M. Baggiolini, and I. Clark-Lewis. 2001. The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J. Biol. Chem. 276:2986-2991.
50. Luther, S. A., and J. G. Cyster. 2001. Chemokines as regulators of T cell differentiation. Nat. Immunol. 2:102-107.
51. Madsen, A. N., A. Nansen, J. P. Christensen, and A. R. Thomsen. 2003. Role of macrophage inflammatory protein-1α in T-cell-mediated immunity to viral infection. J. Virol. 77:12378-12384.
52. Mantovani, A. 1999. The chemokine system: redundancy for robust outputs. Immunol. Today 20:254-257.
53. Marker, O., A. Scheynius, J. P. Christensen, and A. R. Thomsen. 1995. Virus-activated T cells regulate expression of adhesion molecules on endothelial cells in sites of infection. J. Neuroimmunol. 62:35-42.
54. Marker, O., and M. Volkert. 1973. Studies on cell-mediated immunity to lymphocytic choriomeningitis virus in mice. J. Exp. Med. 137:1511-1525.
55. Masopust, D., K. Murali-Krishna, and R. Ahmed. 2007. Quantitating the magnitude of the lymphocytic choriomeningitis virus-specific CD8 T-cell response: it is even bigger than we thought. J. Virol. 81:2002-2011.
56. Matyszak, M. K., and V. H. Perry. 1996. The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system. Neuroscience 74:599-608.
57. Medawar, P. B. 1948. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br. J. Exp. Pathol. 29:58-69.
58. Mims, C. A. 1960. Intracerebral injections and the growth of viruses in the mouse brain. Br. J. Exp. Pathol. 41:52-59.
59. Murphy, P. M. 2001. Viral exploitation and subversion of the immune system through chemokine mimicry. Nat. Immunol. 2:116-122.
60. Nansen, A., J. P. Christensen, S. O. Andreasen, C. Bartholdy, J. E. Christensen, and A. R. Thomsen. 2002. The role of CC chemokine receptor 5 in antiviral immunity. Blood 99:1237-1245.
61. + T cells increase during viral infection and migrate to sites of infection. Eur. J. Immunol. 30:1797-1806.
62. Pichlmair, A., O. Schulz, C. P. Tan, T. I. Näslund, P. Liljeström, F. Weber, and C. Reis e Sousa. 2006. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314:997-1001.
63. Price, D. A., P. Klenerman, B. L. Booth, R. E. Phillips, and A. K. Sewell. 1999. Cytotoxic T lymphocytes, chemokines and antiviral immunity. Immunol. Today 20:212-216.
64. Rossi, D., and A. Zlotnik. 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18:217-242.
65. Sallusto, F., A. Lanzavecchia, and C. R. Mackay. 1998. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol. Today 19:568-574.
66. Schrum, S., P. Probst, B. Fleischer, and P. F. Zipfel. 1996. Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta, and RANTES is associated with a type 1 immune response. J. Immunol. 157:3598-3604.
67. Schwendemann, G., J. Lohler, and F. Lehmann-Grube. 1983. Evidence for cytotoxic T-lymphocyte-target cell interaction in brains of mice infected intracerebrally with lymphocytic choriomeningitis virus. Acta Neuropathol. 61:183-195.
68. + T cells trafficking to cerebrospinal fluid in HIV-1 infection. J. Infect. Dis. 189:2202-2212.
69. Sorensen, T. L., M. Tani, J. Jensen, V. Pierce, C. Lucchinetti, V. A. Folcik, S. Qin, J. Rottman, F. Sellebjerg, R. M. Strieter, J. L. Frederiksen, and R. M. Ransohoff. 1999. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Investig. 103:807-815.
70. Stevenson, P. G., S. Hawke, D. J. Sloan, and C. R. M. Bangham. 1997. The immunogenicity of intracerebral virus infection depends on anatomical site. J. Virol. 71:145-151.
71. + T cell trafficking following viral infection of the CNS. Eur. J. Immunol. 36:613-622.
72. + T cells mediate fatal lymphocytic choriomeningitis despite impaired cytokine production. J. Virol. 80:1222-1230.
73. Thomsen, A. R., A. Nansen, and J. P. Christensen. 1998. Virus-induced T cell activation and the inflammatory response. Curr. Top. Microbiol. Immunol. 231:99-123.
74. Thomsen, A. R., A. Nansen, A. N. Madsen, C. Bartholdy, and J. P. Christensen. 2003. Regulation of T cell migration during viral infection: role of adhesion molecules and chemokines. Immunol. Lett. 85:119-127.
75. Thomsen, A. R., M. Volkert, and O. Marker. 1979. The timing of the immune response in relation to virus growth determines the outcome of the LCM infection. Acta Pathol. Microbiol. Scand. Sect. C 87C:47-54.
76. Wagner, L., O. O. Yang, E. A. Garcia-Zepeda, Y. Ge, S. A. Kalams, B. D. Walker, M. S. Pasternack, and A. D. Luster. 1998. Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature 391:908-911.
77. Weng, Y., S. J. Siciliano, K. E. Waldburger, A. Sirotina-Meisher, M. J. Staruch, B. L. Daugherty, S. L. Gould, M. S. Springer, and J. A. DeMartino. 1998. Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J. Biol. Chem. 273:18288-18291.
78. Wildbaum, G., N. Netzer, and N. Karin. 2002. Plasmid DNA encoding IFN-gamma-inducible protein 10 redirects antigen-specific T cell polarization and suppresses experimental autoimmune encephalomyelitis. J. Immunol. 168:5885-5892.
79. Yoneyama, H., S. Narumi, Y. Zhang, M. Murai, M. Baggiolini, A. Lanzavecchia, T. Ichida, H. Asakura, and K. Matsushima. 2002. Pivotal role of dendritic cell-derived CXCL10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes. J. Exp. Med. 195:1257-1266.
80. Zlotnik, A., and O. Yoshie. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12:121-127.